Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia
Author:
Affiliation:
1. Department of Drug Metabolism and Pharmacokinetics,
2. Department of Pharmacology and Toxicology, and
3. Department of Medicinal chemistry, Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India
Publisher
Informa UK Limited
Subject
Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/00498254.2016.1278287
Reference28 articles.
1. Buch A, Maroni B, Hartman C. (2015). Dose exposure relationship of vadadustat is independent of the level of renal function. American Society of Nephrology Kidney Week Annual Meeting; 2015 Nov 3–8; San Diego, CA, USA (Abstract Program #SA-PO537)
2. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
3. The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review
4. Role of hepcidin in the pathophysiology and diagnosis of anemia
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies;Science Bulletin;2023-09
2. Impact of Disease States on the Oral Pharmacokinetics of EIDD-1931 (an Active Form of Molnupiravir) in Rats for Implication in the Dose Adjustment;Molecular Pharmaceutics;2023-08-01
3. Nonclinical Pharmacokinetic Evaluation of Desidustat: a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia;European Journal of Drug Metabolism and Pharmacokinetics;2022-07-26
4. Desidustat: First Approval;Drugs;2022-07
5. Prolyl hydroxylase inhibitor desidustat protects against acute and chronic kidney injury by reducing inflammatory cytokines and oxidative stress;Drug Development Research;2021-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3